UBE2K modulators and methods for their use
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
1. A compound of the Formula:
or a pharmaceutically acceptable salt of any of the foregoing.
2. The compound of claim 1 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.
3. The compound of claim 1 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 1 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.
5. A pharmaceutical composition comprising a compound of the Formula:
or a pharmaceutically acceptable salt of any of the foregoing; and a pharmaceutically acceptable carrier.
6. The composition of claim 5 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.
7. The composition of claim 5 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.
8. The composition of claim 5 , wherein the compound is of the Formula:
or a pharmaceutically acceptable salt thereof.